Join
Live feed
·
INSIDERFilingvia Quantisnow
Viracta Therapeutics Inc. logo

SEC Form 4: Rojkjaer Lisa converted options into 4,127 shares and sold $5,754 worth of shares (2,116 units at $2.72), increasing direct ownership by 5% to 46,116 units (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIRX (Viracta Therapeutics Inc.) and more on Quantisnow.